|
GB202017671D0
|
|
Novel syringe
|
|
GB202009917D0
|
|
Process for the preparation of iopamidol
|
|
GB202004773D0
|
|
Continuous crystallisation method
|
|
GB201919073D0
|
|
Novel manufacturing process
|
|
WO2019207078A1
|
|
Gadolinium deposition detection and quantification
|
|
GB201821049D0
|
|
Ultrasound contrast agent and methods for use therof
|
|
GB201820732D0
|
|
Novel manufacturing process
|
|
GB201809404D0
|
|
Method of synthesis
|
|
GB201804835D0
|
|
Formulation and method of preparation
|
|
EP3558394A1
|
|
Tetraazabicyclo-macrocycle based manganese chelate compounds suitable as mri imaging agents
|
|
GB201721669D0
|
|
Novel Manufacturing process
|
|
GB201721463D0
|
|
Tailored dose of contrast agent
|
|
GB201703227D0
|
|
Plastic containers
|
|
CN108289970A
|
|
Include the preparation of the combination of MRI contrast agent
|
|
GB201610738D0
|
|
Chelate compounds
|
|
GB201522412D0
|
|
Dota synthesis
|
|
US2017157316A1
|
|
Deflectable plunger head
|
|
WO2015101541A1
|
|
Tamper-evident cap assembly for a container
|
|
WO2015082719A1
|
|
Alternative acetylation process in the synthesis of non-ionic xray contrast agents
|
|
GB201421161D0
|
|
Metal complex formulations
|
